World Journal of Gastroenterology · 2006 · 119 citations · 18 references
Life SciencesBiochemistryCell BiologyApoptosisHepatologyInflammationBcl-2 Family ProteinsHepatic PathophysiologyLiver DiseaseMetabolic Liver DiseaseAnti-apoptotic Bcl-2 Protein InhibitionBcl-2 Protein ExpressionHepatic ApoptosisImmunohistochemical MarkersImmunohistochemical StainingP53-mediated ApoptosisPro-apoptotic Bax ActivationPro-apoptotic Bcl-2 Proteins
AIM: To analyze the protein expression essential for apoptosis in liver steatosis. METHODS: The expression of proapoptotic proteins p53, Bax, and antiapoptotic Bcl-2 in hepatocytes with steatosis (SH) and without steatosis (NSH) was evaluated in 84 patients at various stages of non-alcoholic fatty liver disease (NAFLD). RESULTS: Immunohistochemical staining of liver tissue showed the activation of p53 protein in SH and NSH with increased liver steatosis, diminished Bcl-2 and slightly decreased Bax protein. Positive correlation was found between the stage of liver steatosis with p53 expression in SH (r = 0.54, P < 0.01) and NSH (r = 0.49, P < 0.01). The antiapoptotic protein Bcl-2 was diminished together with the advancement of liver steatosis, especially in non-steatosed hepatocytes (r = 0.43, P < 001). CONCLUSION: Apoptosis is one of the most important mechanisms leading to hepatocyte elimination in NAFLD. The intensification of inflammation in NAFLD induces proapoptotic protein p53 with the inhibition of antiapoptotic Bcl-2.
18
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations · Full text
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Paul Angulo, Jill C. Keach, Kenneth P. Batts et al. · Hepatology · 1999 · 1.6K citations · Full text